Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912950 · ClinicalTrials.gov registry record · NA
Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair
A NA study of Hypertrichosis, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01912950: Completed NA study of Hypertrichosis, sponsored by Cutera.
NCT01912950 is a NA study of Hypertrichosis that has completed, run by Cutera. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01912950, a NA study of Hypertrichosis, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized, controlled, open-label pilot study is to evaluate the safety and efficacy of a novel intense pulsed light (IPL) device for removal of unwanted fine body hair. Subjects will have IPL treatment on one forearm area. Another area will serve as the un-treated control area. Subjects will be followed at 12-weeks post-final treatment.
Conditions Studied
Interventions
- DEVICE Prowave LX IPL
Study Locations (1)
New York
- Sadick Research Group - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT01912950 record still lists
NCT01912950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hypertrichosis appearing as the primary indexed condition, and to 1 intervention - of which Prowave LX IPL is the first listed.
NCT01912950 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01912950 about?
NCT01912950 is a clinical study titled "Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair". The purpose of this randomized, controlled, open-label pilot study is to evaluate the safety and efficacy of a novel intense pulsed light (IPL) device for removal of unwanted fine body hair. Subjects will have IPL treatment on one forearm area. Another area will serve as the un-treated control area...
What is the current status of trial NCT01912950?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-12. Estimated completion is 2015-07.
What conditions does trial NCT01912950 study?
This clinical trial studies the following conditions: Hypertrichosis.
What interventions are being tested in trial NCT01912950?
The interventions under investigation include: Prowave LX IPL (DEVICE).
Who is sponsoring clinical trial NCT01912950?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01912950 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrichosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01912950's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia